A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis
2006 ◽
Vol 194
(6)
◽
pp. 1616-1624
◽
2020 ◽
Vol 79
(Suppl 1)
◽
pp. 784.3-784